S. Mamede do Coronado, Portugal

Paula Jeronimo


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paula Jeronimo: Innovator in Cardiovascular Medicaments

Introduction

Paula Jeronimo is a distinguished inventor based in S. Mamede do Coronado, Portugal. She has made significant contributions to the field of medicinal chemistry, particularly in the treatment of cardiovascular diseases. Her innovative work has led to the development of a unique patent that addresses critical health issues.

Latest Patents

Paula Jeronimo holds a patent for "Processes for preparing medicaments for the treatment of cardiovascular diseases and intermediates for use therein." This invention provides a compound of formula N, where X can be CH, oxygen, or sulphur. The compounds are particularly useful as intermediates in the synthesis of peripherally-selective inhibitors of dopamine-β-hydroxylase. The patent outlines various processes for preparing these compounds, which can significantly impact cardiovascular treatment options.

Career Highlights

Throughout her career, Paula has demonstrated a commitment to advancing medical science. Her work at Bial-Portela & Ca S.A. has positioned her as a key player in the pharmaceutical industry. She has focused on developing innovative solutions that can improve patient outcomes in cardiovascular health.

Collaborations

Paula has collaborated with notable colleagues, including Domenico Russo and Jorge Wahnon. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medicinal chemistry.

Conclusion

Paula Jeronimo's contributions to the field of cardiovascular medicaments highlight her innovative spirit and dedication to improving healthcare. Her patent represents a significant advancement in the treatment of cardiovascular diseases, showcasing her role as a leading inventor in this critical area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…